Dominique P V de Kleijn
Overview
Explore the profile of Dominique P V de Kleijn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
207
Citations
6440
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kraaijvanger R, Janssen Bonas M, Paspali I, Grutters J, Veltkamp M, de Kleijn D, et al.
ERJ Open Res
. 2025 Mar;
11(2).
PMID: 40040892
Background: ∼30% of patients with sarcoidosis, a systemic granulomatous disease of unknown cause, need treatment to alleviate symptoms or prevent organ damage. Prednisone and methotrexate (MTX) are the most commonly...
2.
Mohammadnia N, van Broekhoven A, Bax W, Eikelboom J, Mosterd A, Fiolet A, et al.
Eur J Prev Cardiol
. 2024 Oct;
PMID: 39478683
Aims: Inflammatory lipoprotein(a) [Lp(a)] and oxidized phospholipids (OxPLs) on lipoproteins convey residual cardiovascular disease risk. The LoDoCo2 (low-dose colchicine 2) trial showed that colchicine reduced the risk for cardiovascular events...
3.
Kleinbongard P, Arriola C, Badimon L, Crisostomo V, Giricz Z, Gyongyosi M, et al.
Basic Res Cardiol
. 2024 Oct;
119(6):893-909.
PMID: 39422732
Numerous cardioprotective interventions have been reported to reduce myocardial infarct size (IS) in pre-clinical studies. However, their translation for the benefit of patients with acute myocardial infarction (AMI) has been...
4.
Kraaijenhof J, Mol B, Nurmohamed N, Dzobo K, Kroon J, Hovingh G, et al.
Atherosclerosis
. 2024 Aug;
396:118532.
PMID: 39153264
Background And Aims: Systemic low-grade inflammation, measured by plasma high-sensitivity C-reactive protein (hsCRP) levels, is an important risk factor for atherosclerotic cardiovascular disease (ASCVD). To date, however, it is unknown...
5.
Lan T, Palm K, Hoeben L, Diez Benavente E, Perry R, Civelek M, et al.
Atherosclerosis
. 2024 Aug;
397:118554.
PMID: 39137621
Background And Aims: Tobacco smoking is a known risk factor for atherosclerotic disease, with more elevated risks in women compared to men. We hypothesized that atherosclerotic plaques from smokers show...
6.
Mol B, Verwer M, Fijnheer R, Florie J, Groot O, Hietbrink F, et al.
PLoS One
. 2024 May;
19(5):e0302830.
PMID: 38722842
Introduction: The risk of major bleeding complications in catheter directed thrombolysis (CDT) for acute limb ischemia (ALI) remains high, with reported major bleeding complication rates in up to 1 in...
7.
Diez Benavente E, Hartman R, Sakkers T, Wesseling M, Sloots Y, Slenders L, et al.
Arterioscler Thromb Vasc Biol
. 2024 Apr;
44(6):1419-1431.
PMID: 38634280
Background: Epigenetic age estimators (clocks) are predictive of human mortality risk. However, it is not yet known whether the epigenetic age of atherosclerotic plaques is predictive for the risk of...
8.
Kraaijvanger R, Janssen Bonas M, Grutters J, Paspali I, Veltkamp M, de Kleijn D, et al.
Respir Res
. 2024 Apr;
25(1):166.
PMID: 38627696
Background: Sarcoidosis is a systemic granulomatous disease of unknown etiology primarily affecting the lungs. Treatment is needed when disease symptoms worsen and organ function deteriorates. In pulmonary sarcoidosis, prednisone and...
9.
Klokman V, Koningstein F, Dors J, Sanders M, Koning S, de Kleijn D, et al.
Acad Emerg Med
. 2024 Feb;
31(4):371-385.
PMID: 38403938
Background/introduction: In patients with acute vestibular syndrome (AVS), differentiating between stroke and nonstroke causes is challenging in the emergency department (ED). Correct diagnosis of vertigo etiology is essential for early...
10.
Dzobo K, Cupido A, Mol B, Stiekema L, Versloot M, Winkelmeijer M, et al.
Arterioscler Thromb Vasc Biol
. 2024 Jan;
44(3):720-740.
PMID: 38269588
Background: Oxidized phospholipids play a key role in the atherogenic potential of lipoprotein(a) (Lp[a]); however, Lp(a) is a complex particle that warrants research into additional proinflammatory mediators. We hypothesized that...